Lisa Rotenstein is an Internal Medicine Resident at Brigham and Women's Hospital. She received her MD/MBA with Honors from Harvard Medical School/Harvard Business School, and graduated Magna Cum Laude and Phi Beta Kappa from Harvard College. Rotenstein is also the Co-Founder of CareZooming, a learning and collaboration platform for physicians and administrators seeking to improve healthcare delivery systems. In 2017, Rotenstein was named one of MedTech Boston's 40 Under 40 Healthcare Innovators. Her award-winning research and writing has been published in The New England Journal of Medicine, JAMA, and The Lancet, and is spotlighted by a 2017 NEJM article on the potential of patient reported outcomes, a 2016 JAMA meta-analysis on depression in medical students that was featured in over 70 major news outlets, including Time Magazine, Forbes, and CNN, and 2018 NEJM and Annals of Internal Medicine articles on gender bias in medicine. Rotenstein's care delivery innovation work has spanned complex care planning, patient reported outcomes, physician wellness, and clinical pathways. Prior to medical school she worked in the diabetes space, and was the lead author for the book “Targeting a Cure for Type 1 Diabetes” and multiple articles on diabetes therapeutics.